- About Us
- Education & Training
- UTHealth Home
The Institute for Stroke and Cerebrovascular Disease at UTHealth was formed to sustain and grow research and training opportunities in stroke and cerebrovascular disease across the various schools at UTHealth. Stroke is a major global health problem and we are uniquely positioned at UTHealth to take advantage of the wonderful expertise at the McGovern Medical School, School of Public Health, School of Nursing, School of Dentistry, the Graduate School of Biomedical Sciences, and School of Biomedical Informatics to build upon our existing accomplishments and broaden our research footprint into such areas as stroke prevention, stroke recovery, population health, personalized medicine, biomarkers, and health services research.
The stroke program at UTHealth was started by James Grotta in 1979 and was supported by the cerebrovascular disease related research interests of the first two Department of Neurology Chairmen (Bill Fields–management of extracranial carotid disease and Frank Yatsu –stroke risk factors). The program was initially shaped by important collaborations with faculty in stroke epidemiology, clinical trial design, and basic science, and the Houston Emergency Medical Services (EMS). It was the first Stroke Center established in Houston at the Memorial Hermann Texas Medical Center hospital and was one of the first established in the world.
Publication of first clinical trials of Carotid Endarterectomy and of Aspirin for stroke prevention (Dr. Fields).
The stroke program was started by James Grotta upon his arrival in Houston.Founding Details
NIH and industry funded clinical stroke trials get under way.Clinical Stroke Trials Details
Formation of a separate in-patient clinical stroke service at Memorial Hermann HospitalStroke Program Details
Implemented the First Joint Commission Certified Integrated System of Comprehensive Stroke Centers
The stroke program was started by James Grotta upon his arrival in Houston.
All stroke patients at Memorial Hermann Hospital admitted to Neurology in-patient service.
Dr. Grotta also initiates AHA and NIH funded laboratory investigations of cerebral blood flow and metabolism.
The program admits the first stroke fellow (Dr. Creed Pettigrew). It eventually becomes the largest stroke fellowship program in the country.
The first NIH T32 funded stroke training program is started.
To learn more about our current fellowship programs, click here.
A lead site in numerous NIH and industry funded translational studies of “neuroprotective” agents taken from bench to bedside.
A lead site in the successful NINDS tPA Stroke Trial establishing the first effective treatment for acute stroke.
SPOTRIAS P50 NINDS program grant to conduct specialized translational research to develop novel acute stroke therapies including Argatroban and Ultrasound for acute ischemic stroke, Pioglitizone for intracerebral hemorrhage.
First translational regenerative medicine program in stroke conducting cell-based therapies in stroke (Dr. Savitz).
The largest Regional Coordinating Center spanning Texas, Oklahoma, and Louisiana in the NINDS Stroke Network (StrokeNet) (Dr. Savitz).
Launched the first Mobile Stroke Unit (MSU) in the US in a prospective study funded by AHA and PCORI (Dr. Grotta).
Read more about our current fellowship programs.
Formation of a separate in-patient clinical stroke service at Memorial Hermann Hospital.
Formation of “stroke team” concept; collaboration with Houston EMS with emphasis on early notification and treatment.
Formation of a dedicated Stroke Unit at Memorial Hermann Hospital; the first in Texas, and possibly in the U.S.
First telemedicine program in the region.
First in patient neuro-rehabilitation service in region.
First neuro ICU service in region.
Dr. Wu joined the Memorial Hermann stroke network and created a large network that treats over 500 stroke patients with t-PA
First Mobile Stroke Unit in U.S. (Dr. Grotta).
First Integrated Stroke System of Comprehensive Stroke Centers in the U.S. (Drs. Savitz, Day, Kim).
At UTHealth, we have several international leaders in stroke and cerebrovascular disease.
James Grotta, MD
Founder, Stroke Program
Director, Mobile Stroke Consortium
Jaroslaw (Jarek) Aronowski, MD, PhD
Vice-Chair, Research Department of Neurology
Louise McCullough, MD, PhD
Chair, Department of Neurology
Dong Kim, MD
Chair, Department of Neuosurgery
Arthur Day, MD
Vice-Chair, Department of Neurosurgery